Loading company…
Protomer Technologies developed protein therapeutics that respond to molecular activators in the body.
Founded in 2014 and based in California, Protomer Technologies developed therapeutic proteins for metabolic diseases, including diabetes. Eli Lilly and Company acquired the company in July 2021 for USD 1 billion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in